ImStem Biotechnology
Business Services · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Farmington Ave, Farmington, Connecti...Phone Number
(860) 281-7836Website
www.imstem.comRevenue
<$5 MillionIndustry
About ImStem Biotechnology
ImStem Biotechnology is an innovative biopharmaceutical company that focuses on pioneering stem cell technology to develop transformative medicines for patients with autoimmune, degenerative, and rare diseases. Their proprietary T-MSC technology differentiates human embryonic stem cells into mesenchymal stem cells, which are currently being studied in clinical trials for multiple sclerosis. The company aims to improve treatment outcomes and quality of life for patients through their advanced research and development efforts. Founded in 2012, ImStem is committed to translating scientific research into effective therapies.Explore more
ImStem Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to ImStem Biotechnology
Compare insights from companies similar to ImStem Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ImStem Biotechnology
<$5M
11-50
Private
<$5M
2012
XW
Xiaofang WangVice President and Chief Technology Officer and Founder
ImStem Biotechnology Tech Stack
A closer look at the technologies used by ImStem Biotechnology
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ImStem Biotechnology
Sign Up For FreeTo access detailed company insights
ImStem Biotechnology is an innovative biopharmaceutical company that focuses on pioneering stem cell technology to develop transformative medicines for patients with autoimmune, degenerative, and rare diseases. Their proprietary T-MSC technology differentiates human embryonic stem cells into mesenchymal stem cells, which are currently being studied... Read More
